ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Biden-Harris admin has 'failed' repeatedly on health care: analysis

The Health Markets Policy Network criticizes the Biden-Harris administration for diverting $266 billion from Medicare to green energy policies.

The Biden-Harris administration's handling of health care policies under the Inflation Reduction Act (IRA) has resulted in the $266 billion diversion from Medicare to green energy – leading to a 21.5% increase in Part D premiums and a drastic reduction in available plans – according to an analysis by the Health Market and Policy Network, led by Joe Grogan, former domestic policy assistant under the Trump administration.

The administration's intervention, including a $10 billion subsidy to insurers, is a temporary measure to mask the deeper issues created by these changes, the analysis sent to health care groups on Monday said.

The analysis, which comes just one day before the presidential debate between Vice President Kamala Harris and former President Trump, also criticized the administration's handling of the Affordable Care Act (ACA) and Medicare Advantage (MA) plans for allegedly enabling widespread fraud and costing billions, while cuts and stricter regulations have made it harder for seniors to access benefits. 

HEALTH CARE IS ‘OVERWHELMINGLY COMPLEX’ FOR OLDER ADULTS, EXPERTS SAY: ‘EVER-INCREASING HURDLE’

"With a presidential debate looming and a quick sprint to Election Day, health care policy will be debated vigorously," Grogan told Fox News Digital. "Because many in the legacy media have been all too eager to advance the Biden administration's progressive narrative that only greater government control and more deficit spending will make America healthier, a more sober assessment of the Biden-Harris record is essential to help Americans understand the issues." 

"Our brief analysis reveals a series of failures in health care policy – catastrophically flawed legislation, counterproductive regulations, and an executive branch more committed to control than positive health care outcomes," he added.

The analysis also states that the Biden-Harris administration "suppressed medical perspectives counter to their preferred narratives and censored dissident scientists."

By boosting subsidies and offering free plans to people above the poverty line, they encouraged some to falsely claim low incomes, the report claimed. As a result, up to 5 million people were fraudulently enrolled, costing taxpayers $15 billion to $20 billion in 2024. 

"Due to poor oversight of ACA brokers, reports broke this year of ACA plans being switched and of thousands of other Americans being enrolled in ACA-backed plans, all without their knowledge or consent," the report states.

The Biden-Harris administration's changes to Medicare Advantage (MA) plans have also reduced payments to insurers and made it harder for these plans to offer extra benefits for seniors. New restrictions and lower payments may lead to higher costs for beneficiaries and fewer benefits like dental and vision care, according to the report.

The administration also "prioritized radical identity politics over medical expertise," according to the analysis, and in 2021, they offered extra pay to doctors who made plans to focus on race in their care. They also required brain research groups to include diversity goals in their funding applications.

BIDEN-HARRIS ADMINISTRATION USING TAXPAYER MONEY TO MASK MEDICARE PREMIUM HIKES BEFORE ELECTION: CRITICS

In a move critics say is designed to shield the Biden-Harris administration from election fallout, the administration also leveraged taxpayer funds to mask upcoming increases in Medicare premiums last month.

Under the IRA, which was intended to cap out-of-pocket drug costs for Medicare beneficiaries, insurers are poised to significantly hike monthly premiums, with average bids for Part D plans expected to triple by 2025.

Americans are also dealing with a spike in the cost of prescription drugs, which has surged nearly 40% over the past decade, easily outstripping the pace of inflation. 

In response to potential voter backlash, the Centers for Medicare and Medicaid Services (CMS) rolled out a three-year "demonstration project" to subsidize these premiums in August, aiming to keep them artificially low. However, despite the appearance of relief, some critics are saying that taxpayers will fund a dramatic increase in subsidies – from $30 per recipient per month in 2024 to $142.70 in 2025 – raising concerns about the long-term impact on government spending and debt. 

Fox News Digital has reached out to the White House for comment but did not hear back by publication deadline. 

FOX Business' Megan Henney contributed to this report. 

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.